ATMARAM BAMNIYA

Social worker

[Blockchain For Impact (Official) @BFI_Impact]

Whether it’s cancer, tuberculosis, or neurological disorders, early diagnosis can significantly improve treatment outcomes. Yet, many diseases continue to be detected only after symptoms appear or significant damage has already occurred. One of the biggest reasons is that disease biomarkers exist in the blood at extremely low concentrations during the early stages, making them difficult to detect with conventional diagnostic methods.
This is the challenge that ANLISA Biotech is working to solve.

Founded by Dr. Balendu Avvaru, ANLISA is developing an ultrasensitive molecular detection platform capable of detecting biomarkers at attomolar concentrations, up to 1000× greater sensitivity than conventional ELISA, using a simple blood sample. By identifying biomarkers that conventional methods may miss, the platform aims to enable earlier diagnosis while remaining compatible with standard laboratory equipment, making advanced diagnostics more accessible and scalable.

ANLISA’s current focus is on neurological diseases, where the platform is designed to detect biomarkers such as NFL, tau, GFAP, and α-synuclein without the need for invasive CSF collection. The company is also building ultrasensitive immunoassays for oncological and infectious diseases, opening the possibility of applying the same detection approach across multiple disease areas in the future.

As healthcare shifts towards prevention and early intervention, technologies that can detect disease at the molecular level have the potential to transform healthcare by allowing disease to be identified and addressed before it progresses, potentially reducing the need for intensive treatment.

[Blockchain For Impact (Official) @BFI_Impact]

Introducing the team of innovation enablers of the BFI NAMAH Program at mPragati, IIT Delhi, with multidisciplinary expertise in CNC machining, advanced manufacturing, AI, embedded systems, product engineering, regulatory affairs, and MedTech innovation.

When the innovators arrive, they'll find more than infrastructure. They'll be supported by the expertise, mentorship, and hands on guidance needed to turn ideas into impactful MedTech solutions.

For any query please reach out to [email protected]

[Blockchain For Impact (Official) @BFI_Impact]

Every cell in our body carries genes that carefully regulate its growth and trigger cell death when something goes wrong. These built-in safeguards prevent damaged or abnormal cells from multiplying uncontrollably. However, cancer cells find ways to bypass these natural defenses.

One of the mechanisms they use involves proteins called Histone Deacetylases (HDACs), which can switch off genes responsible for controlling cell growth and initiating cancer cell death. Among them, HDAC3 plays a critical role in helping cancer cells survive, proliferate, and even resist existing therapies. While several HDAC inhibitor drugs are already available, most target multiple HDAC proteins simultaneously, often causing unwanted side effects by affecting healthy cells.

Supported by BFI-BIOME, Prof. Balaram Ghosh and his team at BITS Pilani Hyderabad Campus are developing AH22, a novel and highly selective HDAC3 inhibitor designed to precisely reactivate the body’s natural cancer-suppressing genes. By selectively blocking HDAC3, AH22 aims to restore the cell’s ability to eliminate cancer cells while minimizing damage to healthy tissues.

The team is now advancing AH22 through preclinical translation, generating the critical safety and efficacy data needed before it can enter human clinical trials. If successful, this targeted therapy could pave the way for safer, more effective cancer treatments that overcome drug resistance and improve outcomes for patients.

[Blockchain For Impact (Official) @BFI_Impact]

NAMAH under BFI Innovation Full Stack helps biomedical innovators transform their proof of concept or prototype into a regulatory compliant, design for manufacturing ready product.

If you are building a medical device, IVD, implant, assistive technology, or another biomedical innovation, we invite you to apply.

Applications close on 31st July 2026.

Learn more about the program: https://t.co/FoKKWoKEy6

Apply through Interconnect: https://t.co/XTLtMPFVWe

@sandeepnailwal @GITAMUniversity @NimsUniversity @iiscbangalore @bitspilaniindia @IGIBSocial @AIC_CCMB @iitbombay @aiims_newdelhi @AshokaUniv @THSTIFaridabad @iitdelhi @venture_center @biubareilly @IKP_SciencePark
@StJohns_Blr @kd_medical @phiaindia @CCAMP_India @incubatorIITK @fitt_iitd

[Blockchain For Impact (Official) @BFI_Impact]

BFI Innovation Full Stack brings prototyping, clinical validation, large scale field studies, and market access onto one platform, with structured support at every stage, and room for innovators to join at any point in their journey, from prototyping to near market readiness.

Deadline's approaching, don't wait to apply.
Application deadline for Cohort 1: 31 July 2026

Apply now via Interconnect: https://t.co/XTLtMPGtLM
Learn more: https://t.co/FoKKWoLcnE

@GITAMUniversity @NimsUniversity @iiscbangalore @bitspilaniindia @IGIBSocial @AIC_CCMB @iitbombay
@aiims_newdelhi @AshokaUniv @THSTIFaridabad

[Blockchain For Impact (Official) @BFI_Impact]

Imagine a patient waiting for a life saving medicine, unaware that the medicine may have already lost its effectiveness before it reaches the hospital or clinic.

For temperature sensitive therapies, even a few minutes at the wrong temperature can compromise its effectiveness. The result? Millions of dollars’ worth of medicines are wasted every year, treatments are delayed, and patients may not receive the care they need. In fact, an estimated 25% of biologics are discarded due to temperature excursions during storage and transportation.

That’s where Phloton comes in.
Phloton is an active cooling solution that continuously maintains the required 2–8°C temperature range during transport. Unlike conventional cold boxes that rely on ice packs and passive cooling, Phloton actively regulates temperature to help ensure temperature-sensitive healthcare products reach their destination safely and remain effective.

As biologics and other advanced therapies become more common, innovations like Phloton are helping make healthcare delivery more reliable, efficient, and accessible.

If you want to connect with innovators like Prerit Mittal, Suraj J R, and hundreds of others tackling some of healthcare’s most pressing challenges, join Interconnect, a platform where biomedical researchers, clinicians, founders, investors, and industry experts connect, collaborate, and build the future of healthcare together.

Download Interconnect today.

Google Play: https://t.co/zAUUvNFiu6

App Store: https://t.co/yCmmyuFMiQ

@prerit_mittal @sandeepnailwal

[Blockchain For Impact (Official) @BFI_Impact]

Clinical validation shouldn’t be limited due to access or connections.

This program brings innovators and clinicians together within structured hospital ecosystems to help accelerate innovations into validated products with clinical insights.

Apply now via Interconnect: https://t.co/XTLtMPGtLM
Learn more: https://t.co/FoKKWoLcnE

Application Deadline for Cohort 1: 31st July 2026

@GITAMUniversity @NimsUniversity @iiscbangalore @bitspilaniindia @IGIBSocial @AIC_CCMB @iitbombay @aiims_newdelhi @AshokaUniv @THSTIFaridabad

[Blockchain For Impact (Official) @BFI_Impact]

Applications for BFI Innovation Full Stack are open until 31st July.

Applying is simple:

•⁠ ⁠Download the Interconnect app from the Google Play Store or Apple App Store.
•⁠ ⁠Register yourself or your organization.
•⁠ ⁠Publish your project on Interconnect (this is a mandatory step before applying).
•⁠ ⁠Start your application, choose the BFI Innovation Full Stack program that best fits your needs, complete the required details, and submit.

Learn more: https://t.co/2vbNYjgp27

Download Interconnect: https://t.co/D2SRCxtxBF…
Read more

@sandeepnailwal

[Blockchain For Impact (Official) @BFI_Impact]

Over 1.5 million people are diagnosed with cancer in India every year, and a significant proportion of them require chemotherapy as part of their treatment.

While chemotherapy remains one of the most effective cancer treatments, it is not selective, it attacks rapidly dividing healthy cells along with cancer cells.

As a result, patients often experience debilitating side effects such as fatigue, nausea, hair loss, immune suppression, and organ toxicity. These side effects can reduce quality of life, limit the dose of chemotherapy that patients can tolerate, and sometimes even interrupt treatment.

Exsure is working to address this challenge through an exosome-based targeted drug delivery platform. Exosomes are tiny, naturally occurring vesicles released by cells that act as biological messengers. Exsure engineers these exosomes to carry anti-cancer drugs directly to tumors, allowing medicines to be delivered more precisely to cancer cells while minimizing exposure to healthy tissues. The platform is also being designed to target cancer stem cells, which are believed to contribute to tumor recurrence and treatment resistance.

By making chemotherapy more targeted, Exsure aims to improve treatment effectiveness while reducing its harmful side effects. If successful, this approach could enable safer cancer therapies, improve patients’ quality of life during treatment, and reduce the likelihood of cancer relapse, ultimately benefiting a large number of cancer patients who depend on chemotherapy each year.

[Blockchain For Impact (Official) @BFI_Impact]

The best conversations begin with great questions.

Have a question about biosciences, digital health, healthcare innovation, or the future of research? Share it with us for the upcoming Science.Unblocked Podcast featuring Dr. Anurag Agrawal, hosted by Dr. Gaurav Singh.

Submit your question using the QR code or via: https://t.co/wlQY0nGp2a

[Blockchain For Impact (Official) @BFI_Impact]

After product development and validation, one of the biggest challenges healthcare startups face is achieving real market adoption.

Establishing presence within hospitals, navigating procurement systems, building clinical trust, generating clinical prescriptions, and scaling commercially can often be more difficult than developing the innovation itself.

The Product Promotion Program is designed to address this challenge by connecting innovators with the right stakeholders, enabling clinical adoption, and helping innovators reach the right markets.

Apply now via Interconnect: https://t.co/XTLtMPGtLM
Learn more: https://t.co/FoKKWoLcnE

@GITAMUniversity @NimsUniversity @iiscbangalore @bitspilaniindia @IGIBSocial @AIC_CCMB @iitbombay @aiims_newdelhi @AshokaUniv @THSTIFaridabad

[Blockchain For Impact (Official) @BFI_Impact]

BFI signed a historic MOU with IIT Bombay under Bharat Innovates Program at NICE France. Partnership was announced by Hon. Commerce Minister Shri Piyush Goyal and Principal Scientific Advisor to PMO Dr Ajay Sood. The event was graced by Prime Minister Narendra Modi and French President Emmanuel Macron.

BFI along with IIT Bombay will work to support biomedical startups from ideation to market access in collaboration with European ecosystem of Universities, hospitals and Investors.

[Blockchain For Impact (Official) @BFI_Impact]

From weekly mentoring sessions to now engaging directly with the European innovation ecosystem, BFI VK Connect has officially entered its immersion phase in Barcelona.

Over the past few months, the programme has supported some of India’s most promising healthcare startups through expert sessions, mentorship, market validation and internationalisation strategy development.

Now, the selected startups are on ground in Europe, connecting with mentors, healthcare stakeholders, innovation hubs and industry experts to better understand the European healthcare market and explore pathways for global expansion.

This immersion phase is about creating meaningful exposure and helping Indian healthcare innovators build the networks, insights and market understanding needed to scale beyond borders.

[Blockchain For Impact-BFI @BFI_Impact_]

The BFI team visited Bareilly International University (BIU), the first partner in the Medical College Incubation Centre Program, to formalize the partnership and explore opportunities to strengthen innovation at the intersection of medicine and technology.

The visit began with the signing of the MoU in the presence of Dr. Lata Agrawal (Vice Chancellor, BIU; Obstetrics & Gynaecology), Dr. Varun Agrawal (Board Member; Orthopedic and Spine Specialist), Dr. Arjun Agarwal (Board Member; Surgical Oncologist), and Mr. Claudius Lazarus (CEO, Bareilly Medtech Incubation and Innovation Labs (BMIIL); experienced in tech startups and incubation ecosystems), whose expertise and leadership will play a key role in supporting the program.

This was followed by a walkthrough of key institutions including Rohilkhand Medical College and Hospital, Institute of Dental Sciences, Bareilly Medtech Incubation and Innovation Labs (BMIIL), and Rohilkhand Ayurvedic Medical College and Hospital to understand the clinical, academic, and innovation ecosystem. The team had focused interactions with BMIIL team, clinicians and innovators, gaining firsthand perspectives on emerging ideas and opportunities within the academic and clinical ecosystem, aligned with the broader vision of strengthening clinician led innovation and enabling scalable impact in healthcare research and solutions.

[जनसेवा मित्र संगठन मध्यप्रदेश 🤝 @Bhagwancmyip]

@DrMohanYadav51 हमारे प्रिय यशस्वी मुख्यमंत्री @DrMohanYadav51 जी आपके बच्चे मुख्यमंत्री जनसेवा मित्र को अटल ग्रामीण सेवा सदन बना दीजिए ग्राम पंचायत पर माननीय
@ChouhanShivraj
@BJP4India
@jitupatwari
@JPNadda
@drmohanoffice51
@AIGGPA
@AmitShah
@JM_Scindia
@OfficeofSSC
@vdsharmabjp
@narendramodi

[ATMARAM BAMNIYA @ATMARAMBAMNIYA3]

@DrMohanYadav51 श्री मान जन सेवा मित्रो द्वारा बहुत प्रयास किया गया है और पंचायत स्तर पर वास्तविक हकदार वही है उनको मौका मिलना चाहिए

[Uttam singh Sengar @UttamSenga41004]

जन सेवा मित्रो ने गांव गांव जाकर किया प्रचार प्रसार आज क्यों है बेरोजगार।
#शिवराज_के_जनसेवा_मित्र
@ChouhanShivraj
@DrMohanYadav51
@rshuklabjp
@prahladspatel
@JagdishDevdaBJP

[जगदीश पुरी @jagdish236sh]

शिवराज सरकार में मामा के जो युवा हुआ करते थे आंख,कान, नाक वे है आज बेरोजगार भूखे और प्यासे।
#जनसेवा_मित्रों_को_बहाल_करो
@ChouhanShivraj
@DrMohanYadav51
@rshuklabjp
@prahladspatel
@JagdishDevdaBJP